Loading...
Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens
Background. The optimal retreatment strategy for chronic hepatitis C virus (HCV) patients who fail directly-acting antiviral agent (DAA)-based treatment is unknown. In this study, we assessed the efficacy and safety of ledipasvir (LDV) and sofosbuvir (SOF) for 12 weeks in HCV genotype-1 (GT-1) patie...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706633/ https://ncbi.nlm.nih.gov/pubmed/26521268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ874 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|